Renal dysfunction and anemia associated with long-term imatinib treatment in patients with chronic myelogenous leukemia
Sign Up to like & getrecommendations! Published in 2019 at "International Journal of Hematology"
DOI: 10.1007/s12185-019-02596-z
Abstract: Knowledge of the toxicity profile of long-term treatment with imatinib is limited. In the present study, we sought to evaluate renal function and hemoglobin levels during long-term imatinib treatment. Eighty-two patients with chronic myelogenous leukemia… read more here.
Keywords: renal dysfunction; long term; term imatinib; hemoglobin levels ... See more keywords